Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RESCUE MeVO: Intra-arterial Thrombolysis for Acute Ischemic Stroke with Medium Vessel Occlusion
NCT07185022Recruiting
- Sponsor
- The Second Affiliated Hospital of Anhui Medical University
- Start
- Jan 2026
- Primary completion
- Feb 2030
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
Randomised, open-label trial of tenecteplase in ischemic stroke (2 arms), sponsored by The Second Affiliated Hospital of Anhui Medical University. Primary endpoint: Excellent outcome (mRS 0-1) at 90 days. Started Jan 2026; status: recruiting.
02
Drugs
tenecteplase
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT07185022.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07185022.